Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
PCSA similar filings
- 11 Feb 25 Regulation FD Disclosure
- 10 Feb 25 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
- 30 Jan 25 Processa Pharmaceuticals Announces Pricing of $5 Million Public Offering Priced At-The- Market Under Nasdaq Rules
- 6 Nov 24 Changes in Registrant's Certifying Accountant
- 2 Oct 24 Processa Pharmaceuticals Announces First Patient Dosed in Phase 2 Clinical Trial of NGC-Cap in Metastatic Breast Cancer
- 28 Aug 24 Processa Pharmaceuticals Provides Product Pipeline and Financial Update
- 30 Jul 24 Processa Pharmaceuticals Announces FDA Clearance of IND Application for a Phase 2 Clinical Trial of NGC-Cap in Breast Cancer
Filing view
External links